info@news-matic.com

details

Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company's Pioneering Work in Mitochondrial Medicine

/PRNewswire/ -- Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development, and... – Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership – – Appointment signals expansion of executive team to support a growing proprietary pipeline in rare and age-related diseases of mitochondrial d... [3996 chars]

Cookie Consent + Tracking